Levoxyl and Mycophenolate mofetil drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Levoxyl (levothyroxine sodium) and Mycophenolate mofetil (mycophenolate mofetil). Common drug interactions include pain among females and kidney transplant rejection among males.
The phase IV clinical study analyzes what interactions people have when they take Levoxyl and Mycophenolate mofetil. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.
What is Levoxyl?
Levoxyl has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 25,178 Levoxyl users. Check the latest studies of Levoxyl.
What is Mycophenolate mofetil?
Mycophenolate mofetil has active ingredients of mycophenolate mofetil. It is often used in myasthenia gravis. eHealthMe is studying from 93,460 Mycophenolate mofetil users. Check the latest studies of Mycophenolate mofetil.
19 people who take Levoxyl and Mycophenolate mofetil together, and have interactions are studied.

What are the common drug interactions of Levoxyl and Mycophenolate Mofetil, by gender? *:
female:
- Pain
- Arthritis (form of joint disorder that involves inflammation of one or more joints)
- Headache (pain in head)
- Kidney infection
- Multiple allergies (allergy to multiple agents)
- Urinary tract infection
- Fall
- Fatigue (feeling of tiredness)
- Syncope (loss of consciousness with an inability to maintain postural tone)
- Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)
male:
- Kidney transplant rejection
- Epstein-barr virus associated lymphoproliferative disorder (lymphocytes are produced in excessive quantities associated with epstein-barr virus)
- Diarrhoea
- Dizziness
- Dysuria (painful or difficult urination)
- Emotional distress
- Facial spasm (involuntary muscle contractions face)
- Fatigue (feeling of tiredness)
- Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
- Gastric disorder (disease of stomach)
What are the common drug interactions of Levoxyl and Mycophenolate Mofetil, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Kidney transplant rejection
- Epstein-barr virus associated lymphoproliferative disorder (lymphocytes are produced in excessive quantities associated with epstein-barr virus)
- Hepatic lesion
- Asthenia (weakness)
- Cytomegalovirus infection
- Diarrhoea
- Facial spasm (involuntary muscle contractions face)
- Haematochezia (passage of stools containing blood)
- Hypersensitivity
- Monocytosis (an increase in the number of monocytes circulating in the blood)
40-49:
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Arthralgia (joint pain)
- Bone pain
- Dry skin
- Emotional disorder
- Gait disturbance
- Injury
- Mobility decreased (ability to move is reduced)
- Muscular weakness (muscle weakness)
50-59:
- Asthenia (weakness)
- Blood creatinine increased
- Blood potassium decreased
- Chest pain
- Dizziness
- Dysuria (painful or difficult urination)
- Fatigue (feeling of tiredness)
- Gastric disorder (disease of stomach)
- Haematuria (presence of blood in urine)
- Herpes zoster
60+:
- Pain
- Arthritis (form of joint disorder that involves inflammation of one or more joints)
- Oesophageal infection
- Blood pressure decreased
- Dehydration (dryness resulting from the removal of water)
- Disease progression
- Gastrointestinal disorder (functional problems of gastrointestinal tract)
- Heart rate increased
- Insomnia (sleeplessness)
- Nervousness
What are the existing conditions these people have? *
- Osteoporosis (bones weak and more likely to break): 6 people, 31.58%
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 4 people, 21.05%
- Pain: 4 people, 21.05%
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy (long lasting infection of nerves outside brain and spinal cord): 4 people, 21.05%
- Stress And Anxiety: 3 people, 15.79%
- Itching: 3 people, 15.79%
- Nuclear Magnetic Resonance Imaging Abdominal: 3 people, 15.79%
- Nuclear Magnetic Resonance Imaging Brain: 3 people, 15.79%
- High Blood Pressure: 3 people, 15.79%
- Insomnia (sleeplessness): 2 people, 10.53%
* Approximation only. Some reports may have incomplete information.
Do you take Levoxyl and Mycophenolate mofetil?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Levoxyl (25,178 reports)
- Mycophenolate mofetil (93,460 reports)
Browse all drug interactions of Levoxyl and Mycophenolate mofetil:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Levoxyl:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Mycophenolate mofetil:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Levoxyl and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Mycophenolate mofetil and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on levothyroxine sodium and mycophenolate mofetil (the active ingredients of Levoxyl and Mycophenolate mofetil, respectively), and Levoxyl and Mycophenolate mofetil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Zolpidem cause Loss Of Libido? - now
- Could Levetiracetam cause Blood Glucose Decreased? - 9 seconds ago
- Drug interactions of Trental and Hydrodiuril - 10 seconds ago
- Drug interactions of Prozac and Trospium Chloride - 18 seconds ago
- Could Marijuana cause Impaired Healing? - 23 seconds ago
- Could Furosemide cause Allergic Cough? - a minute ago
- Could Indomethacin Sodium cause Sleep Apnea Syndrome? - a minute ago
- Drug interactions of Magnesium Sulfate and Coca - a minute ago
- Could Valium cause Alcohol Withdrawal Syndrome? - a minute ago
- Drug interactions of Acyclovir and Daraprim - 2 minutes ago